Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab

Br J Ophthalmol. 2009 Apr;93(4):557-8. doi: 10.1136/bjo.2008.148148.

Authors

T Kubota¹, R Aoki, Y Harada, N Tou, Y Kohno, A Tawara, H Satoh, S Shimajiri

Affiliation

¹ Department of Ophthalmology, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. tkubota@med.uoeh-u.ac.jp

PMID: 19321485
DOI: 10.1136/bjo.2008.148148

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Angiogenesis Inhibitors / pharmacology*
Antibodies, Monoclonal / pharmacology*
Antibodies, Monoclonal, Humanized
Bevacizumab
Glaucoma, Neovascular / drug therapy*
Humans
Trabecular Meshwork / drug effects*

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab